Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies.

Thibodeaux BA, Panella AN, Roehrig JT.

Clin Vaccine Immunol. 2010 Oct;17(10):1617-23. doi: 10.1128/CVI.00097-10. Epub 2010 Aug 25.

2.

Antibody prophylaxis and therapy for flavivirus encephalitis infections.

Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD.

Ann N Y Acad Sci. 2001 Dec;951:286-97. Review.

PMID:
11797785
3.

Nucleic acid-based inhibition of flavivirus infections.

Stein DA, Shi PY.

Front Biosci. 2008 Jan 1;13:1385-95. Review.

PMID:
17981637
4.

Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis.

Alcon-LePoder S, Sivard P, Drouet MT, Talarmin A, Rice C, Flamand M.

Novartis Found Symp. 2006;277:233-47; discussion 247-53. Review.

PMID:
17319166
5.
6.

Current status of flavivirus vaccines.

Barrett AD.

Ann N Y Acad Sci. 2001 Dec;951:262-71. Review.

PMID:
11797783
7.

Review of diagnostic plaque reduction neutralization tests for flavivirus infection.

Maeda A, Maeda J.

Vet J. 2013 Jan;195(1):33-40. doi: 10.1016/j.tvjl.2012.08.019. Epub 2012 Oct 1. Review.

PMID:
23036176
8.

Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Go YY, Balasuriya UB, Lee CK.

Clin Exp Vaccine Res. 2014 Jan;3(1):58-77. doi: 10.7774/cevr.2014.3.1.58. Epub 2013 Dec 18. Review.

9.

Mouse models of alphavirus-induced inflammatory disease.

Taylor A, Herrero LJ, Rudd PA, Mahalingam S.

J Gen Virol. 2015 Feb;96(Pt 2):221-38. doi: 10.1099/vir.0.071282-0. Epub 2014 Oct 28. Review.

PMID:
25351726
10.

Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Leibovitch EC, Jacobson S.

Neurotherapeutics. 2016 Jul;13(3):562-70. doi: 10.1007/s13311-016-0453-3. Review.

11.

The Brazilian flaviviruses.

Figueiredo LT.

Microbes Infect. 2000 Nov;2(13):1643-9. Review.

PMID:
11113383
12.

Alphaviruses: population genetics and determinants of emergence.

Weaver SC, Winegar R, Manger ID, Forrester NL.

Antiviral Res. 2012 Jun;94(3):242-57. doi: 10.1016/j.antiviral.2012.04.002. Epub 2012 Apr 19. Review.

13.

Arboviral encephalitis and RNAi treatment.

Nogueira ML, Nogueira MC, Pacca C.

Cent Nerv Syst Agents Med Chem. 2011 Dec 1;11(4):296-304. Review.

PMID:
22300230
14.

Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives.

Dupuy LC, Reed DS.

Curr Opin Virol. 2012 Jun;2(3):363-7. doi: 10.1016/j.coviro.2012.02.014. Epub 2012 Mar 21. Review.

PMID:
22709522
15.

Age has a role in driving host immunopathological response to alphavirus infection.

Chan YH, Ng LFP.

Immunology. 2017 Dec;152(4):545-555. doi: 10.1111/imm.12799. Epub 2017 Aug 23. Review.

PMID:
28744856

Supplemental Content

Support Center